Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 819k | $2.2M | -13% | Sep 2025 |
|
| Millennium Management | 416k | $1.1M | -24% | Sep 2025 |
|
| BlackRock | 302k | $804k | -19% | Sep 2025 |
|
| Geode Capital Management | 222k | $591k | 1% | Sep 2025 |
|
| Rbf Capital | 200k | $532k | 0% | Sep 2025 |
|
| Morgan Stanley | 86k | $255k | 100% | Jun 2025 |
|
| Northern Trust | 82k | $217k | -12% | Sep 2025 |
|
| State Street Corporation | 67k | $179k | -2% | Sep 2025 |
|
| Dimensional Fund Advisors | 64k | $171k | -9% | Sep 2025 |
|
| Squarepoint Ops | 62k | $165k | 56% | Sep 2025 |
|
| Bridgeway Capital Management | 60k | $158k | 0% | Sep 2025 |
|
| Empowered Funds | 60k | $158k | 0% | Sep 2025 |
|
| Jane Street | 56k | $148k | 120% | Sep 2025 |
|
| Bank of New York Mellon | 49k | $129k | 0% | Sep 2025 |
|
| Citadel Advisors | 43k | $115k | 32% | Sep 2025 |
|
| Connor, Clark & Lunn Investment Management | 36k | $96k | -25% | Sep 2025 |
|
| Qube Research & Technologies | 30k | $81k | -6% | Sep 2025 |
|
| Hrt Financial | 26k | $69k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 25k | $67k | -47% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 25k | $66k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 21k | $55k | -1% | Sep 2025 |
|
| American Century Companies | 19k | $50k | -27% | Sep 2025 |
|
| Two Sigma Advisers | 16k | $43k | 0% | Sep 2025 |
|
| XTX Topco | 15k | $40k | -26% | Sep 2025 |
|
| TNB Financial | 13k | $36k | 0% | Sep 2025 |
|
| Synovus Financial Corp. | 12k | $31k | 0% | Sep 2025 |
|
| Point72 Asia | 6.8k | $18k | -50% | Sep 2025 |
|
| UBS Group | 6.5k | $17k | 28% | Sep 2025 |
|
| Cubist Systematic Strategies | 5.3k | $14k | -79% | Sep 2025 |
|
| Royal Bank of Canada | 2.8k | $10k | 15% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.4k | $6.3k | -92% | Sep 2025 |
|
| Rhumbline Advisers | 928.00 | $2.5k | 0% | Sep 2025 |
|
| McIlrath & Eck | 753.00 | $2.0k | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 370.00 | $999.000000 | 0% | Sep 2025 |
|
| Simplex Trading | 322.00 | $0 | -63% | Sep 2025 |
|
| FMR | 310.00 | $825.003000 | -84% | Sep 2025 |
|
| Barclays | 207.00 | $550.992600 | 20600% | Sep 2025 |
|
| CWM | 127.00 | $0 | -79% | Sep 2025 |
|
| SRS Capital Advisors | 22.00 | $58.000800 | 100% | Sep 2025 |
|
| Larson Financial Group | 21.00 | $56.000700 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 17.00 | $45.000700 | -45% | Sep 2025 |
|
| Optiver Holding B.V. | 8.00 | $21.000000 | 100% | Sep 2025 |
|
| True Wealth Design | 3.00 | $8.000100 | -57% | Sep 2025 |
|
| Sunbelt Securities | 2.00 | $5.000000 | 100% | Sep 2025 |
|
| SBI Securities | 1.00 | $3.000000 | 0% | Sep 2025 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Y-Intercept | Jun 2025 | 48k | $142k |
| Susquehanna International | Jun 2025 | 39k | $117k |
| Jain Global | Jun 2025 | 18k | $52k |
| Hsbc Holdings | Jun 2025 | 17k | $49k |
| Tower Research Capital | Jun 2025 | 9.3k | $28k |
| Russell Investments | Jun 2025 | 1.4k | $4.2k |
| Raymond James Financial | Jun 2025 | 358.00 | $1.1k |
| Wells Fargo & Company | Jun 2025 | 149.00 | $443.006800 |
| Hartland & Co | Jun 2025 | 17.00 | $51.000000 |